The recommendations in this document describe the current indications for inhaled nitric oxide (iNO) treatment in the newborn and clearly distinguish between those supported by scientific evidence and those for which evidence is still lacking, such as its use in preterm infants. The methodology for iNO administration, its dosage and the main secondary effects are discussed, and the reasons for lack of response to this treatment are analyzed.
|Journal||Anales de Pediatria|
|Publication status||Published - 1 Jan 2006|
- Inhaled nitric oxide
- Pulmonary hypertension